O, A., MY, Y., S, A., MH, E., A, M., M, A., . . . H, A. (2026). Hospitalization, ICU admission, and mortality among diabetic patients with inflammatory bowel disease receiving SGLT-2 inhibitors: A retrospective cohort study from the global collaborative network. Annals of translational medicine, 14(3), 32. https://doi.org/10.21037/atm-2026-0131
Chicago Style (17th ed.) CitationO, Abdelhalim, et al. "Hospitalization, ICU Admission, and Mortality Among Diabetic Patients with Inflammatory Bowel Disease Receiving SGLT-2 Inhibitors: A Retrospective Cohort Study from the Global Collaborative Network." Annals of Translational Medicine 14, no. 3 (2026): 32. https://doi.org/10.21037/atm-2026-0131.
MLA (9th ed.) CitationO, Abdelhalim, et al. "Hospitalization, ICU Admission, and Mortality Among Diabetic Patients with Inflammatory Bowel Disease Receiving SGLT-2 Inhibitors: A Retrospective Cohort Study from the Global Collaborative Network." Annals of Translational Medicine, vol. 14, no. 3, 2026, p. 32, https://doi.org/10.21037/atm-2026-0131.